ABSTRACT
Conclusions: Our findings demonstrated significantly more diagnostic discrepancies and discordance than has been suggested by the previously published literature. A large part of the difference may be due to more careful diagnostic analyses of orthopedic specimens than in other institutions. These analyses include some diagnoses that are not often made elsewhere but may have important future implications for patients.
As health care costs have increased in the United States, there has been increasing pressure to economize by eliminating medical costs that appear to not contribute to the care of individual patients. Performing routine histopathology when acquiring meaningful diagnostic information is considered unlikely is an area that has come under increasing scrutiny. For example, since there is little probability of finding histologic abnormalities in a grossly normal rib excised for access to an open nephrectomy, a simple gross description documenting its excision is considered sufficient for diagnostic and quality assurance purposes. This eliminates the costs associated with its further processing and histologic interpretation. In individual cases, such cost savings are desirable, frequently institutionally dependent, and considered an acceptable tradeoff for potential loss of diagnostic information.
Upon completion of this activity you will be able to:
• predict the rate of discrepancies between clinical and histologic examination of total joint resection specimens.
• list the most common diagnostic entities that may not be suspected on clinical examination and the joint affected (knee vs hip).
• explain the difference in the terms "discordant" and "discrepant" as used in this article, and how this definition can be applied in quality assurance programs.
The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit ™ per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module.
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Questions appear on p 142. Exam is located at www.ascp.org/ajcpcme.
Cost-effectiveness is the comparison of costs incurred vs information gained for a given procedure. It has been analyzed for "routine" histologic examinations, including those in the orthopedic setting. As Raab 1 stated, "From a societal perspective, there is a trade-off between information gained and the costs incurred from microscopic examinations." Netzer et al 2 concluded that it is not necessary to perform microscopic examinations on some surgical specimens (eg, routine tonsillectomies and adenoidectomies), because the total cost of these examinations to society outweighs the total benefit of the information gained. Central to the logic of this viewpoint is that the most important information collected by histologic examination on these tissues should affect individual patient care. 1 Similar opinions have been advanced to eliminate histologic examination of specimens obtained from arthroplasties. It has been argued that eliminating the cost of these examinations benefits individual patients and society as a whole because the reduction in total costs is justified by the lack of disagreement between clinical and pathologic diagnoses, and because minor discrepancies do not change patient management. [3] [4] [5] [6] [7] [8] This point of view assumes that abandoning traditional microscopic examinations does not compromise the quality of care provided to individual patients and the benefit to society.
Not surprisingly, pathologists have authored publications and editorials espousing the contrary viewpoint. [9] [10] [11] Their reasoning has been based on two major premises: first, that some clinically significant and potentially curable diseases may not be detected without histologic examination, and second, that information gathered from such examinations and used for quality assurance purposes, outcomes research, and education is never considered in cost-savings analyses despite the immense and vital, if intangible, benefit of this information to society.
Most of the published studies detailing cost-effectiveness in joint replacements are a decade or more old and, with few exceptions, 4, 5, 7, 8 have evaluated only small numbers of arthroplasties. At our institution, there is a combination of large numbers of arthroplasties, as well as considerable aggregate experience by pathologists specializing in bone and joint diseases, and almost all specimens are examined histologically. We undertook this study, similar to those previously published, to evaluate whether the findings of a much larger patient cohort would be comparable to those in the literature. The study design was not to determine cost analysis but simply to compare the working clinical diagnoses with those made by supplementing the gross pathology with microscopic examination. Our hypothesis, based on the previous literature, was that there would be no significant differences between the clinical and histologic diagnoses.
Materials and Methods
The institutional review board (IRB) of the Hospital for Special Surgery determined that this study met its criteria for Health Insurance Portability and Accountability Act compliance, and study approval was granted (IRB #10075).
All cases of total joint replacements presented in this study are from the 10-year interval between January 2000 and December 2009. This constituted 16,587 cases of total joint replacement specimens representing the sum of 7,968 total hip replacements and 8,619 total knee replacements, all of which had been examined grossly and microscopically by one of us (E.F.D.) and verified by the other (M.J.K.).
Every specimen had been received from the operating room accompanied by a pathology requisition slip bearing identifying data regarding each patient, including the site of excision and the preoperative and postoperative clinical diagnoses. The specimens were examined grossly; relevant sections were made using a motorized band saw (Biro model 22, Biro Manufacturing, Marblehead, OH) and placed in neutral buffered formalin. After fixation, bone specimens were decalcified in dilute (3%) HCl solution containing 0.1% Disodium EDTA (Thermo Fisher Scientific, Waltham, MA) and then washed in tap water. Sections from the bone and the accompanying synovial soft tissues were paraffin embedded, sectioned, and stained with H&E. Sections were examined using a Zeiss Axioskop 40 (Carl Zeiss, Jena, Germany). The diagnoses from the patient reports were compared with the submitting clinical diagnoses using our Pathology Information System WindoPath software (version 5.0; Psyche Systems, Waltham, MA), using Brio Intelligence Explorer (version 6.4.4; Oracle Hyperion, Santa Clara, CA). The only parameters compared were the submitting and microscopic diagnoses; no individual patient identifiers were sought.
A discordant result was defined as a disagreement between the clinically reported and pathologic diagnosis that should not affect patient management. A discrepant result was defined as a disagreement between reported clinical and pathologic diagnoses that should be expected to alter patient management.
The selection of a single pathologist's cases may at first seem constrained or unduly limited, but we believed that it would yield more internal diagnostic consistency than correlating the diagnoses of multiple pathologists for the sole purpose of trebling the number of cases surveyed in this interval. We intend to accomplish the latter in an additional larger study, but in this preliminary examination, one fellowshiptrained orthopedic pathologist's diagnoses were checked for agreement with the opinion of another fellowship-trained orthopedic pathologist having an aggregate experience in bone disease interpretation of more than 65 years. It should be noted that in the Department of Pathology and Laboratory Medicine at the Hospital for Special Surgery, a large sample of cases together representing one in 10 accessioned cases with their pathologic diagnoses is randomly rereviewed histologically for quality assurance on a monthly basis. This review regularly proceeded before, during, and after this interval, and at least one in 10 cases in this study had been reviewed by our entire group. None of the histologic diagnoses of these selected cases had been changed by those reviews (unpublished data from the departmental quality assurance program). The 10-year time interval selected for the study, designated in the United States as the "Bone and Joint Decade," 12 coincides in large part with the availability of the pathology database system, enabling us to undertake the study.
For the purposes of the study, only the seven most common conditions (or groups of related conditions) diagnosed histologically were used as the conditions for which concordance was determined. These are degenerative joint disease, traumatic injury/fracture, avascular necrosis, subchondral insufficiency fracture, rapidly progressive arthritis, inflammatory arthritis, and septic arthritis ❚Table 1❚. Subsets of degenerative joint disease, such as disease secondary to a developmental defect or disease secondary to other preexisting conditions, were included within either the degenerative joint disease category or the category of the primary condition, such as inflammatory arthritis and infection, if such a condition could be identified at the time of pathologic examination.
All pathologic diagnoses were based on the accepted criteria, 13 some of which were developed or refined in this department, for each condition as known at the time of the histologic examination ❚Image 1❚, ❚Image 2❚, and ❚Image 3❚.
Results
Degenerative joint disease, including postdevelopmental degenerative disease and other cases of secondary degenerative disease, constituted the most common condition ❚Image 1❚ Avascular necrosis, femoral head stage 2, demonstrating an articular surface that remains geographically intact and viable. The bone is necrotic all the way to the peripheral zone of reconstruction, seen at the bottom of the section. This can be confirmed by searching for osteocytes at higher power, but the marrow becomes histologically necrotic prior to the osseous changes and is marked by complete loss of adipocytes and pink staining, where there has been saponification of fat or fibrosis (H&E, ×9).
❚Image 2❚ Femoral head with a subarticular insufficiency fracture demonstrating an extensive cartilaginous repair reaction. The fracture has caused a separation of the overlying articular cartilage and subarticular bone. All histologic evidence of osteonecrosis is confined to the region of the fracture between the articular cartilage and the basophilic cartilaginous repair reaction. The bone and marrow within and beneath this reaction are viable and do not have a reactive repair zone (H&E, ×9).
diagnosed histologically in either anatomic location (75.8% in the hip and 89.5% in the knee). The second most common condition was subchondral insufficiency fracture, occurring in 10.9% of hips and 6.5% of knees, respectively. Avascular necrosis was next most common, especially in the hip and much less frequently in the knee. Of the remaining conditions, trauma/fracture, rapidly destructive disease, and infection were slightly more common in the hip than in the knee, while inflammatory arthritis had nearly the same frequency in both joints (Table 1) . Concordant and discordant diagnoses for all diagnoses in each of the two sites are summarized in ❚Figure 1❚. In the hips, the total number of cases for which the clinical diagnosis was verified histologically was 6,467 of 7,968 cases, for a concordance rate of 81.2% (95% CI, 80.8%-81.62%). In the knees, the total number of cases for which the clinical diagnosis was verified histologically was 7,807 of 8,619 cases, for a concordance rate of 90.6% (95% CI, 90.3%-90.6%). Concordant and discordant diagnoses for each of the two sites are also summarized by diagnosis in ❚Table 2❚ and ❚Table 3❚.
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❚Image 3❚ A, Avascular necrosis of the femoral head, stage 2, higher power, subarticular region demonstrating fat necrosis of the marrow with saponification and empty osteocyte lacunae. Since there is osteonecrosis, there is no vascularity and hence no repair reaction (H&E, ×40). B, Femoral head with subarticular insufficiency fracture, higher power, demonstrating osseous and cartilaginous callus between necrotic bone fragments. While the mature vertical trabeculae connecting the articular plate to the underlying bone are necrotic, this is secondary to fracture. The repair tissue between these spicules required an intact vascular supply and is histologically distinct from osteonecrosis (H&E, ×40). Tables 2 and 3 demonstrates the greatest concordance for degenerative joint disease and the least concordance for subarticular insufficiency fractures. Since the articular cartilages were intact in the patients with subarticular insufficiency fracture, the diagnosis is significant, because the symptoms from the acute fracture resulted in arthroplasty surgery. The concordance for each group was better for knee joints than for hip joints except in the diagnosis of avascular necrosis, which is both more common and clinically easier to diagnose in the femoral head than in the femoral condyles or tibial plateau.
Other diagnoses for hips and knees are shown in ❚Table 4❚ and ❚Table 5❚, respectively. As is shown in these tables, in addition to the discordance for the seven most common diagnoses, 5.4% of the hips and 1.4% of the knees contained additional discrepant pathologic findings. As indicated, most of these findings were not suspected clinically. Since none of these diagnoses had been mentioned in the pathology requisition and tumors and pigmented villonodular synovitis often require subsequent management, clinicians were contacted for all three of these classes of divergent findings. The most common malignant process identified incidentally was chronic lymphocytic leukemia/well-differentiated lymphoma. This diagnosis was known to the surgeon preoperatively in about half the cases but was not considered clinically relevant enough to be mentioned in the pathology requisition. In the remaining cases, the reporting of the tumor (or its discovery on the admission blood count) was the first clinical knowledge of the disease. In almost all the occult metastatic tumors, the primary tumor either was not known at the time of surgery or had not been considered clinically relevant (ie, the bone lesion was the first instance of known metastatic carcinoma).
Discussion
Total joint arthroplasty is one of the most successful surgical procedures ever developed, reaching past 95% in situ survival over 15 to 20 years. 14 components, both cemented and noncemented, is remarkable and widely acknowledged. However, this long-term success is not shared equally among the different conditions for which arthroplasty is used. For example, it is recognized that implant survival rates in patients with inflammatory arthritis, developmental and circulatory disorders, and other conditions are less than those for uncomplicated degenerative disease for a number of reasons. [16] [17] [18] [19] [20] These variations in implant survival justify continued attempts at refining the procedure either technically, such as using small incisional or limited compartmental techniques, or by using other biomechanical materials, such as ceramic, metal-on-metal, or other polymeric components. The predictable success of total joint replacement, as well as newly developed more limited procedures, is dependent to some irreducible extent on the clinical condition that the procedure was chosen to treat. Consequently, the ability to take advantage of variations in diagnoses as they are recognized can lead to better choices in the type of procedure and materials used. Accuracy in confirming clinical diagnoses is a quantifiable component of any complete program of quality assurance and prognostic utility. To date, the gold standard for the verification of clinical diagnoses, regardless of the organ system and disease classification, has been and remains histologic diagnosis by properly educated and interested pathologists.
This report is based on such a process of verification. The discordance between the stated clinical diagnosis and the reported pathologic diagnosis is nearly 20% for hips and almost 10% for knees. Therefore, the working hypothesis of this study-namely, that there is no significant difference between the clinical and pathologic diagnoses-should be rejected.
Degenerative joint disease, the most common diagnosis identified pathologically, was also the most common diagnosis reported clinically. However, it was also the most overdiagnosed condition, having been diagnosed approximately 20% more frequently than could be verified pathologically. Even though degenerative joint disease has a high prevalence, it was not always recognized clinically when actually present. For example, patients who were known to have any number of different inflammatory diseases were classified as having inflammatory arthritis clinically when the actual diagnosis was degenerative. This study suggests that patients with inflammatory involvement of some joints can and do appear to have purely degenerative changes in other joints, particularly those studied in this report.
Even though degenerative disease is by far the largest proportion of the reported cases, the information garnered from the less frequently identified conditions provides the most useful information for assessing the accuracy of clinical diagnosis. Prior to the late 1990s, the diagnoses of subchondral insufficiency fracture and even that of rapidly destructive degenerative disease were only rarely recorded. The criteria for making these diagnoses and their significance to the patients who manifest them are not yet fully comprehended clinically. 21, 22 In addition, the histologic criteria (see Images 1-3) may not yet be widely known or applied by pathologists whose primary practice is in general surgical pathology. 23 Results that appear to be statistically significant numerically do not mean that the surgical treatment was not indicated, but the known information specifying that the specific disease entity in fact does have a bearing on the survival of the implant would suggest that the correct identification of the more unusual conditions affecting the large joints is not simply an academic exercise. The fact that this report indicates that only one of the more than 1,400 cases of subchondral insufficiency fractures and not a single case of the more than 170 cases of rapidly progressive and destructive disease occurring totally in the hips and knees were identified clinically suggests that consistent clinical criteria for identifying patients with these conditions still need clarification. If, as suggested, these conditions are indicative of suboptimal mechanical competence of the bone supporting the joints in which they develop, it seems reasonable to assume that the survival rates for total joint replacement in these conditions may differ from those achieved in standard degenerative disease. 22, 24, 25 Equally important but perhaps more controversial is the management of subarticular insufficiency fractures. While surgical treatment by total joint replacement for these fractures is often indicated, it is possible that some patients with this condition who have not undergone joint collapse may heal with conservative management without surgery. This patient population can be identified only if a detailed history and preoperative magnetic resonance imaging studies are performed prior to the institution of joint replacement surgery. Once joint replacement has been performed, the diagnosis of subarticular insufficiency fracture is important, because the implication of this diagnosis is that there exists an underlying treatable condition that, if managed correctly, may prevent or delay the later development of the same condition in another joint. The difficulty here is that studies of such survival and any other potentially clinically relevant features, if any, for these diagnoses can only be undertaken in institutions in which these diagnoses are recognized at the time of the primary arthroplasty.
A common feature of previous reports concerning the utility of pathologic examination is the identification of clinically important secondary or unknown conditions and diseases identified incidentally (ie, discrepant findings). In addition to the frequent discordance in the primary diagnoses identified in this report, we were able to identify other conditions not reported clinically in 5% of hips and 1% of recognized until the end of the 1990s and would not have been discovered without the judicious use of histologic correlation in total joint replacements. 21 While it can be argued that the preoperative diagnosis of subarticular insufficiency fracture would not have changed surgical management in most cases, its histologic confirmation should have a profound effect on patient follow-up and management because the failure to modify patient behavior or give preventative treatment may result in later fractures.
Even if subarticular insufficiency fractures are ignored, there would have been more discordance between our clinical and histologic diagnoses than has been reported in the orthopedic literature. 13 This is not because of any flaw in our surgical colleagues; to the contrary, orthopedics is practiced here at the highest level. We believe that these diagnostic disagreements are more likely due to the fact that excised joints and particularly their accompanying synovial tissues are examined more thoroughly and comprehensively here in a background of greater osseous histologic experience and perspective than for sections of surgical pathology in most institutions.
We believe our statistics come closer to a real assessment of the actual worth of histology in evaluating joint replacements than the decade-old literature attempting to analyze cost-effectiveness based on prior diagnostic data. Histologic examinations of many tissue types are not costeffective, and given the time necessary to process and study orthopedic tissues, it is already reflected in the low reimbursement rates of third-party payers.
It is clear that the diagnosis affects the survival of a total joint replacement. If, as we believe, diagnostic accuracy is compromised without histologic correlation of the gross specimen, then histologic study of resection specimens can provide an accurate diagnosis that may lead to more meaningful prognostication for both patient and implant. In addition, the continued study of joint specimens provides opportunities to discover new conditions and permits data collections to form the basis of translational research, allowing certain diagnoses to be identified and treated soonerperhaps even before the need for total joint replacement.
Finally, and perhaps most important, quality assurance in histologic diagnosis requires repeated comparison with the largest baseline of specimens possible if pathologists are expected to have the ability to identify what is histologically abnormal. Using our institutional figures for the cost of medical care, the total savings incurred by the elimination of histologic examinations is less than 0.5% of overall medical costs (unpublished data). Before we elect to save 0.5% of medical costs by eliminating histologic examinations, we must ask ourselves if it is worth eliminating 100% of the quality assurance to do so. knees (Tables 4 and 5 ). These incidentally identified conditions included Paget disease, hyperparathyroidism, lymphoma and leukemia, and occult metastases. Likewise, other features of cases that cannot be identified with any degree of consistency preoperatively, such as the type and degree of inflammation in the synovium and the presence of trabecular microfractures in the cancellous bone, cannot be evaluated by gross examination of specimens. These alterations may have an effect on the outcome survival of the prosthesis. However, they can only be evaluated when they are accurately identified and put into clinical perspective. Finally, the discovery of incidental conditions, such as pigmented villonodular synovitis and enchondroma, although not necessarily affecting the course of an individual patient, adds information on the natural history of these conditions that may affect their diagnosis and differential diagnosis when they are suspected or identified in other patients.
The literature reviewing the utility of histologic assessment of joint replacement tissues is small in absolute numbers of articles and emphasizes cost-effectiveness for its arguments. With a few exceptions, the studies are relatively small collections of data from institutions in which orthopedic specimens are a small component of the overall diagnostic load of surgical pathology. 5, 6, 13 Proper examination of orthopedic specimens also requires appropriate knowledge perspective, including understanding the imaging findings and their role in influencing the pathologic diagnosis. Thus, discordant diagnoses also reflect the complementary nature of clinical and pathologic diagnoses, and this is especially important in orthopedic pathology. In addition, since orthopedic specimens require postfixation manipulation and decalcification, they are more difficult, time-consuming, and expensive to process and interpret than nonosseous sites. Consequently, nontumorous orthopedic specimens have become relegated to the mundane in many general pathology departments, not only in their speed of diagnosis but in their degree of diagnostic sophistication. If an entire class of specimens is considered dull and uninteresting, their analysis can be expected to yield little practical information. Consequently, it is understandable that the performance of microscopic examinations and the technical and professional costs associated with them should be criticized in the literature.
In summary, our information demonstrates that the discordance rate between clinically reported and pathologic diagnoses is much higher than in the previously published literature. Although limited in ambition and scope, to our knowledge, this series is many times larger than any previously published study concerning clinicopathologic correlation for diseases of the large joints. Some of this discordance is undoubtedly higher because a few pathologic diagnoses, such as subarticular insufficiency fractures, were not fully
